L J Hak - JoVE Visualize

Showing results (41-50 of 43) with videos related to

Pageof 5

Sort By:

You have reached the last page of results.This site can display upto 43 results.

Journal of Clinical Pharmacology|March 1, 1996

Pharmacokinetics of ondansetron in patients with hepatic insufficiencyW D Figg, G E Dukes, J F Pritchard, et al.

Clinical Pharmacology and Therapeutics|November 1, 1996

Disposition of didanosine in HIV-seropositive patients with normal renal function or chronic renal failure: influence of hemodialysis and continuous ambulatory peritoneal dialysisC A Knupp, L J Hak, D F Coakley, et al.

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 29, 2000

Hypersensitivity or development of antibodies to asparaginase does not impact treatment outcome of childhood acute lymphoblastic leukemiaM H Woo, L J Hak, M C Storm, et al.

Pageof 5

Showing results (41-50 of 43) with videos related to

Sort By:

Pageof 5

You have reached the last page of results.This site can display upto 43 results.

Journal of Clinical Pharmacology|March 1, 1996

Pharmacokinetics of ondansetron in patients with hepatic insufficiencyW D Figg, G E Dukes, J F Pritchard, et al.

Clinical Pharmacology and Therapeutics|November 1, 1996

Disposition of didanosine in HIV-seropositive patients with normal renal function or chronic renal failure: influence of hemodialysis and continuous ambulatory peritoneal dialysisC A Knupp, L J Hak, D F Coakley, et al.

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 29, 2000

Hypersensitivity or development of antibodies to asparaginase does not impact treatment outcome of childhood acute lymphoblastic leukemiaM H Woo, L J Hak, M C Storm, et al.

Pageof 5